| ZEB1-AS1 | non small cell lung cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31949753 | 2018 |
| ZEB1-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 29886791 | 2018 |
| ZEB1-AS1 | glioma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29863254 | 2018 |
| ZEB1-AS1 | gastric cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29771411 | 2018 |
| ZEB1-AS1 | prostate cancer | qPCR, Western blot etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32275162 | 2020 |
| ZEB1-AS1 | breast cancer | qPCR, Western blot etc | H | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 32210737 | 2020 |
| ZEB1-AS1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32190742 | 2020 |
| ZEB1-AS1 | bladder cancer | qPCR, Luciferase reporter assay, RIP, Western blot | H | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30823924 | 2019 |
| ZEB1-AS1 | triple negative breast cancer | qRT-PCR, RIP, Dual-luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31922280 | 2020 |
| ZEB1-AS1 | colon adenocarcinoma | qRT-PCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 31828845 | 2020 |
| ZEB1-AS1 | bladder cancer | qRT-PCR , Western blot , RIP , in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31115480 | 2019 |
| ZEB1-AS1 | glioma | RT-qPCR, in vitro knockdown etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 31186725 | 2019 |
| ZEB1-AS1 | liver cancer | qRT-PCR, Western blotting etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 30988735 | 2019 |
| ZEB1-AS1 | non small cell lung cancer | qPCR, Luciferase reporter assay, Western blot, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30448056 | 2018 |
| ZEB1-AS1 | cervical cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✔ | ✘ | 30425516 | 2018 |
| ZEB1-AS1 | cervical cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | 30253398 | 2019 |
| ZEB1-AS1 | melanoma | qPCR, Luciferase reporter assay, in vitro knockdown, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 30651872 | 2019 |
| ZEB1-AS1 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP, etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30626729 | 2019 |
| ZEB1-AS1 | oesophageal squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 31638344 | 2019 |
| ZEB1-AS1 | B cell acute lymphoblastic leukemia | qPCR, Western blot, RIP | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28861713 | 2017 |
| ZEB1-AS1 | prostate cancer | Western blot, Luciferase reporter, RIP | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28830551 | 2017 |
| ZEB1-AS1 | esophageal squamous cell carcinoma | qPCR etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 26617942 | 2015 |
| ZEB1-AS1 | gastric cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29113674 | 2017 |
| ZEB1-AS1 | bladder cancer | qPCR | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28445936 | 2017 |
| ZEB1-AS1 | glioma | qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✔ | ✘ | 27589728 | 2016 |
| ZEB1-AS1 | hepatocellular carcinoma | microarray, qPCR etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27894309 | 2016 |
| ZEB1-AS1 | colorectal cancer | qRT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29511455 | 2018 |
| ZEB1-AS1 | osteosarcoma | qPCR;Western blot;etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28075045 | 2017 |
| ZEB1-AS1 | gastric cancer | qPCR, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29215918 | 2018 |
| ZEB1-AS1 | colorectal cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | 28618933 | 2017 |
| ZEB1-AS1 | osteosarcoma | qPCR, RNAi, Western blot, RIP, ChIP, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | 27829995 | 2016 |
| ZEB1-AS1 | hepatocellular carcinoma | microarray, qPCR, RNAi etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | 26073087 | 2015 |
| ZEB1-AS1 | gastric cancer | qPCR | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29771411 | 2018 |
| ZEB1-AS1 | colorectal cancer | Flow cytometry assay, qPCR, Western blot, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 29886791 | 2018 |
| ZEB1-AS1 | glioma | qPCR, RNAi, Western blot, Luciferase reporter assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29863254 | 2018 |
| ZEB1-AS1 | Colorectal cancer liver metastases | qRT-PCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 34081622 | 2021 |